Payment overview · 2025
General Payments
$360.90
5 reported records · 4 companies
Healthcare provider profile · identity verified
Gregory Robert Joyner, FNP-C
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · EAST RIDGE, TN · NPI 1831242049
Verified facts
What the public records show
CMS Open Payments records show Gregory Robert Joyner, FNP-C received $360.90 in general payments during 2025 across 5 reported records.
Kerecis Limited accounted for 58.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Rexulti by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Kerecis Limited | Unresolved — no canonical attribution shown | $210.48 | 58.3% | 1 | 2025 |
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $63.86 | 17.7% | 1 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $55.03 | 15.2% | 2 | 2025 |
| Alpha Cognition USA, Inc. | Unresolved — no canonical attribution shown | $31.53 | 8.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $360.90 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Kerecis GraftGuide Normalized: kerecis graftguide |
Device | Kerecis Limited | $210.48 | 1 | 2025 |
Source payment records
|
|||||
| Kerecis SurgiClose Normalized: kerecis surgiclose |
Device | Kerecis Limited | $210.48 | 1 | 2025 |
Source payment records
|
|||||
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $63.86 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $55.03 | 2 | 2025 |
Source payment records
|
|||||
| Zunveyl Normalized: zunveyl |
Drug | Alpha Cognition USA, Inc. | $31.53 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| REXULTI rexulti |
2025 | Rexulti | 2024 | 15 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 941 | 130 |
| Atorvastatin Calcium | Atorvastatin Calcium | 840 | 121 |
| Donepezil Hcl | Donepezil Hcl | 813 | 110 |
| Amlodipine Besylate | Amlodipine Besylate | 778 | 118 |
| Quetiapine Fumarate | Quetiapine Fumarate | 711 | 107 |
| Memantine Hcl | Memantine Hcl | 682 | 95 |
| Furosemide | Furosemide | 679 | 121 |
| Potassium Chloride | Potassium Chloride | 644 | 101 |
| Eliquis | Apixaban | 593 | 93 |
| Losartan Potassium | Losartan Potassium | 572 | 81 |
| Pantoprazole Sodium | Pantoprazole Sodium | 569 | 89 |
| Buspirone Hcl | Buspirone Hcl | 556 | 86 |
| Metoprolol Tartrate | Metoprolol Tartrate | 493 | 73 |
| Sertraline Hcl | Sertraline Hcl | 482 | 77 |
| Omeprazole | Omeprazole | 461 | 71 |
| Escitalopram Oxalate | Escitalopram Oxalate | 456 | 69 |
| Tamsulosin Hcl | Tamsulosin Hcl | 448 | 70 |
| Gabapentin | Gabapentin | 421 | 72 |
| Mirtazapine | Mirtazapine | 416 | 61 |
| Lisinopril | Lisinopril | 363 | 50 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 348 | 54 |
| Carvedilol | Carvedilol | 347 | 50 |
| Trazodone Hcl | Trazodone Hcl | 339 | 65 |
| Metoprolol Succinate | Metoprolol Succinate | 337 | 60 |
| Famotidine | Famotidine | 323 | 50 |
| Duloxetine Hcl | Duloxetine Hcl | 273 | 41 |
| Simvastatin | Simvastatin | 250 | 34 |
| Montelukast Sodium | Montelukast Sodium | 241 | 34 |
| Tramadol Hcl | Tramadol Hcl | 215 | 58 |
| Hydrochlorothiazide | Hydrochlorothiazide | 201 | 41 |
| Spironolactone | Spironolactone | 198 | 32 |
| Clopidogrel | Clopidogrel Bisulfate | 189 | 28 |
| Pravastatin Sodium | Pravastatin Sodium | 184 | 27 |
| Finasteride | Finasteride | 178 | 22 |
| Hydralazine Hcl | Hydralazine Hcl | 174 | 30 |
| Metformin Hcl | Metformin Hcl | 174 | 33 |
| Xarelto | Rivaroxaban | 165 | 21 |
| Fluticasone Propionate | Fluticasone Propionate | 163 | 47 |
| Myrbetriq | Mirabegron | 154 | 21 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 142 | 28 |
| Torsemide | Torsemide | 140 | 24 |
| Allopurinol | Allopurinol | 131 | 18 |
| Prednisone | Prednisone | 127 | 53 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 122 | 14 |
| Divalproex Sodium | Divalproex Sodium | 120 | 21 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 118 | 25 |
| Ondansetron Hcl | Ondansetron Hcl | 114 | 61 |
| Valsartan | Valsartan | 113 | 16 |
| Lorazepam | Lorazepam | 110 | 36 |
| Clonazepam | Clonazepam | 109 | 19 |
| Bumetanide | Bumetanide | 107 | 22 |
| Bupropion Xl | Bupropion Hcl | 107 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 105 | 18 |
| Levetiracetam | Levetiracetam | 100 | 14 |
| Meloxicam | Meloxicam | 100 | 19 |
| Latanoprost | Latanoprost | 96 | 18 |
| Alendronate Sodium | Alendronate Sodium | 95 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 92 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 87 | 73 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 85 | 11 |
| Amiodarone Hcl | Amiodarone Hcl | 81 | 14 |
| Celecoxib | Celecoxib | 80 | 11 |
| Atenolol | Atenolol | 78 | suppressed |
| Risperidone | Risperidone | 78 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 75 | 12 |
| Ropinirole Hcl | Ropinirole Hcl | 74 | suppressed |
| Ezetimibe | Ezetimibe | 70 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 70 | suppressed |
| Nifedipine Er | Nifedipine | 69 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 68 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 68 | 45 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 66 | 27 |
| Midodrine Hcl | Midodrine Hcl | 65 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 64 | 15 |
| Methenamine Hippurate | Methenamine Hippurate | 63 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 63 | suppressed |
| Alprazolam | Alprazolam | 62 | 11 |
| Farxiga | Dapagliflozin Propanediol | 62 | 11 |
| Fluconazole | Fluconazole | 61 | 44 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 61 | suppressed |
| Nystatin | Nystatin | 60 | 38 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 58 | 16 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 57 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 56 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 54 | suppressed |
| Calcitriol | Calcitriol | 53 | suppressed |
| Chlorthalidone | Chlorthalidone | 52 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 51 | suppressed |
| Levofloxacin | Levofloxacin | 48 | 47 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 47 | 39 |
| Lamotrigine | Lamotrigine | 47 | suppressed |
| Sucralfate | Sucralfate | 47 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 46 | suppressed |
| Lactulose | Lactulose | 44 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 44 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 43 | 14 |
| Cephalexin | Cephalexin | 42 | 33 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 41 | 28 |
| Amantadine | Amantadine Hcl | 39 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 39 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 38 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 38 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 38 | suppressed |
| Azithromycin | Azithromycin | 37 | 31 |
| Methocarbamol | Methocarbamol | 37 | 12 |
| Mupirocin | Mupirocin | 37 | 23 |
| Olanzapine | Olanzapine | 37 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 37 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 36 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 36 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 36 | suppressed |
| Pregabalin | Pregabalin | 36 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 35 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 34 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 34 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Aripiprazole | Aripiprazole | 33 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 33 | suppressed |
| Glipizide | Glipizide | 33 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 33 | 19 |
| Jardiance | Empagliflozin | 33 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 33 | suppressed |
| Linzess | Linaclotide | 32 | 11 |
| Glimepiride | Glimepiride | 31 | suppressed |
| Januvia | Sitagliptin Phosphate | 30 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 30 | suppressed |
| Timolol Maleate | Timolol Maleate | 30 | suppressed |
| Anastrozole | Anastrozole | 29 | suppressed |
| Digoxin | Digoxin | 29 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 29 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 29 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 28 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 28 | suppressed |
| Dexamethasone | Dexamethasone | 28 | suppressed |
| Fenofibrate | Fenofibrate | 28 | suppressed |
| Irbesartan | Irbesartan | 28 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 28 | 21 |
| Warfarin Sodium | Warfarin Sodium | 28 | suppressed |
| Amoxicillin | Amoxicillin | 27 | 21 |
| Clonidine | Clonidine | 27 | suppressed |
| Entresto | Sacubitril/Valsartan | 27 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 27 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 27 | suppressed |
| Temazepam | Temazepam | 27 | suppressed |
| Topiramate | Topiramate | 27 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 26 | 24 |
| Novolog Flexpen | Insulin Aspart | 26 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 25 | suppressed |
| Gemtesa | Vibegron | 25 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 25 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 24 | suppressed |
| Lovastatin | Lovastatin | 24 | suppressed |
| Nadolol | Nadolol | 24 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 24 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 23 | suppressed |
| Glipizide Er | Glipizide | 23 | suppressed |
| Methotrexate | Methotrexate Sodium | 23 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 23 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 23 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 23 | suppressed |
| Primidone | Primidone | 23 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 22 | suppressed |
| Belsomra | Suvorexant | 22 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 22 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 22 | suppressed |
| Baclofen | Baclofen | 21 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 21 | suppressed |
| Rivastigmine | Rivastigmine | 21 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 19 | suppressed |
| Loperamide | Loperamide Hcl | 19 | suppressed |
| Unifine Safecontrol Pen Needle | Pen Needle,dual Safety,diabetc | 19 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 18 | suppressed |
| Lubiprostone | Lubiprostone | 18 | suppressed |
| Restasis | Cyclosporine | 18 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 17 | suppressed |
| Erythromycin | Erythromycin Base | 17 | suppressed |
| Folic Acid | Folic Acid | 17 | suppressed |
| Mesalamine Dr | Mesalamine | 17 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 17 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 17 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 16 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 16 | suppressed |
| Estradiol | Estradiol | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Tradjenta | Linagliptin | 16 | suppressed |
| Brilinta | Ticagrelor | 15 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 15 | suppressed |
| Nyamyc | Nystatin | 15 | 12 |
| Rexulti | Brexpiprazole | 15 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 15 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 14 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 14 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 14 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Hydrocortisone | Hydrocortisone | 14 | 13 |
| Ketoconazole | Ketoconazole | 14 | suppressed |
| Metolazone | Metolazone | 14 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 14 | suppressed |
| Ramipril | Ramipril | 14 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 14 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Lumigan | Bimatoprost | 13 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 13 | suppressed |
| Ondansetron Odt | Ondansetron | 13 | 11 |
| Ramelteon | Ramelteon | 13 | suppressed |
| Sotalol | Sotalol Hcl | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 12 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Cosopt Pf | Dorzolamide/Timolol/Pf | 12 | suppressed |
| Entacapone | Entacapone | 12 | suppressed |
| Febuxostat | Febuxostat | 12 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Hydroxyurea | Hydroxyurea | 12 | suppressed |
| Indapamide | Indapamide | 12 | suppressed |
| Mexiletine Hcl | Mexiletine Hcl | 12 | suppressed |
| Mounjaro | Tirzepatide | 12 | suppressed |
| Naproxen | Naproxen | 12 | suppressed |
| Ozempic | Semaglutide | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Selegiline Hcl | Selegiline Hcl | 12 | suppressed |
| Silodosin | Silodosin | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Trimethoprim | Trimethoprim | 12 | suppressed |
| Trospium Chloride | Trospium Chloride | 12 | suppressed |
| Acamprosate Calcium | Acamprosate Calcium | 11 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 11 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 11 | suppressed |
| Clotrimazole | Clotrimazole | 11 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 11 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Mirabegron Er | Mirabegron | 11 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 11 | suppressed |
| Np Thyroid | Thyroid,pork | 11 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $360.90 · 5 records | Kerecis Limited | Auvelity, Kerecis GraftGuide, Kerecis SurgiClose, REXULTI, Zunveyl | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Rexulti play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Otsuka America Pharmaceutical, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error